Silence Releases New Data on Cancer Drug, In Talks for Needed Investment
June 07, 2012
Silence Releases New Data on Cancer Drug, In Talks for Needed Investment
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Silence Plans $28.6M Stock Sale to Fund Expansion of Staff, Pipeline
April 11, 2013 / Gene Silencing News - After Losing Another CEO, Silence Management Aims to Fill in Corporate Gaps
March 21, 2013 / Gene Silencing News - Silence Cleared to Test Cancer Drug in Pancreatic Cancer
March 7, 2013 / Gene Silencing News - IP Update: Recent Patents, Patent Applications Awarded to CalTech, Alnylam, Silence, and More
January 24, 2013 / Gene Silencing News - Silence Reports Higher 1H Loss on Special Charge
October 11, 2012 / Gene Silencing News